These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 35509147)
1. Persistent high-level shedding of cultivable SARS-CoV-2 Delta virus 33 days after onset of COVID-19 in a hospitalized patient with pneumonia. Kim KW; Wang X; Adhikari A; Yeang M; Jenkins F; Naing Z; Walker GJ; Foster CSP; Stelzer-Braid S; Deveson I; Craig ME; Tedla N; Bull RA; Martinello M; Pinto AN; Chan R; Turville S; Rawlinson WD; van Hal S J Med Virol; 2022 Sep; 94(9):4043-4046. PubMed ID: 35509147 [No Abstract] [Full Text] [Related]
2. Persistent viral RNA shedding of SARS-CoV-2 is associated with delirium incidence and six-month mortality in hospitalized COVID-19 patients. Batra A; Clark JR; Kang AK; Ali S; Patel TR; Shlobin NA; Hoffman SC; Lim PH; Orban ZS; Visvabharathy L; Graham EL; Sullivan DP; Muller WA; Chou SH; Ungvári Z; Koralnik IJ; Liotta EM Geroscience; 2022 Jun; 44(3):1241-1254. PubMed ID: 35538386 [TBL] [Abstract][Full Text] [Related]
3. Frequency and Duration of SARS-CoV-2 Shedding in Oral Fluid Samples Assessed by a Modified Commercial Rapid Molecular Assay. Bordi L; Sberna G; Lalle E; Piselli P; Colavita F; Nicastri E; Antinori A; Boumis E; Petrosillo N; Marchioni L; Minnucci G; D'Agostini E; Castilletti C; Locatelli F; Zumla A; Ippolito G; Capobianchi MR; On Behalf Of Inmi ReCOVeRI Study Group Viruses; 2020 Oct; 12(10):. PubMed ID: 33092065 [TBL] [Abstract][Full Text] [Related]
4. Persistent SARS-CoV-2 RNA Shedding Without Evidence of Infectiousness: A Cohort Study of Individuals With COVID-19. Owusu D; Pomeroy MA; Lewis NM; Wadhwa A; Yousaf AR; Whitaker B; Dietrich E; Hall AJ; Chu V; Thornburg N; Christensen K; Kiphibane T; Willardson S; Westergaard R; Dasu T; Pray IW; Bhattacharyya S; Dunn A; Tate JE; Kirking HL; Matanock A; J Infect Dis; 2021 Oct; 224(8):1362-1371. PubMed ID: 33649773 [TBL] [Abstract][Full Text] [Related]
5. Virus shedding dynamics in asymptomatic and mildly symptomatic patients infected with SARS-CoV-2. Li W; Su YY; Zhi SS; Huang J; Zhuang CL; Bai WZ; Wan Y; Meng XR; Zhang L; Zhou YB; Luo YY; Ge SX; Chen YK; Ma Y Clin Microbiol Infect; 2020 Nov; 26(11):1556.e1-1556.e6. PubMed ID: 32653662 [TBL] [Abstract][Full Text] [Related]
6. Factors Associated With Prolonged Viral RNA Shedding in Patients with Coronavirus Disease 2019 (COVID-19). Xu K; Chen Y; Yuan J; Yi P; Ding C; Wu W; Li Y; Ni Q; Zou R; Li X; Xu M; Zhang Y; Zhao H; Zhang X; Yu L; Su J; Lang G; Liu J; Wu X; Guo Y; Tao J; Shi D; Yu L; Cao Q; Ruan B; Liu L; Wang Z; Xu Y; Liu Y; Sheng J; Li L Clin Infect Dis; 2020 Jul; 71(15):799-806. PubMed ID: 32271376 [TBL] [Abstract][Full Text] [Related]
7. Analysis of a persistent viral shedding patient infected with SARS-CoV-2 by RT-qPCR, FilmArray Respiratory Panel v2.1, and antigen detection. Hirotsu Y; Maejima M; Shibusawa M; Amemiya K; Nagakubo Y; Hosaka K; Sueki H; Hayakawa M; Mochizuki H; Tsutsui T; Kakizaki Y; Miyashita Y; Omata M J Infect Chemother; 2021 Feb; 27(2):406-409. PubMed ID: 33183963 [TBL] [Abstract][Full Text] [Related]
8. Diabetes mellitus is a risk factor for prolonged SARS-CoV-2 viral shedding in lower respiratory tract samples of critically ill patients. Buetti N; Trimboli P; Mazzuchelli T; Lo Priore E; Balmelli C; Trkola A; Conti M; Martinetti G; Elzi L; Ceschi A; Consonni V; Ogna A; Forni-Ogna V; Bernasconi E Endocrine; 2020 Dec; 70(3):454-460. PubMed ID: 32870469 [TBL] [Abstract][Full Text] [Related]
9. Clinical predictors and timing of cessation of viral RNA shedding in patients with COVID-19. Corsini Campioli C; Cano Cevallos E; Assi M; Patel R; Binnicker MJ; O'Horo JC J Clin Virol; 2020 Sep; 130():104577. PubMed ID: 32777762 [TBL] [Abstract][Full Text] [Related]
10. Recurrent SARS-CoV-2 RNA positivity and prolonged viral shedding in a patient with COVID-19: a case report. Xiao CH; Chen LF; Li Y BMC Infect Dis; 2021 Oct; 21(1):1076. PubMed ID: 34663257 [TBL] [Abstract][Full Text] [Related]
11. Longer Duration of SARS-CoV-2 Infection in a Case of Mild COVID-19 With Weak Production of the Specific IgM and IgG Antibodies. Guo X; Zeng L; Huang Z; He Y; Zhang Z; Zhong Z Front Immunol; 2020; 11():1936. PubMed ID: 32849650 [No Abstract] [Full Text] [Related]
12. Factors associated with negative conversion of viral RNA in patients hospitalized with COVID-19. Hu X; Xing Y; Jia J; Ni W; Liang J; Zhao D; Song X; Gao R; Jiang F Sci Total Environ; 2020 Aug; 728():138812. PubMed ID: 32335406 [TBL] [Abstract][Full Text] [Related]
13. Prolonged fecal shedding of SARS-CoV-2 in a young immunocompetent COVID-19 patient: A case report and literature overview. Xiao F; Wan P; Wei Q; Wei G; Yu Y J Med Virol; 2022 Jul; 94(7):3133-3137. PubMed ID: 35274321 [TBL] [Abstract][Full Text] [Related]
14. Prolonged viral shedding in severely ill patients infected with SARS-CoV-2 Delta variants: A retrospective cohort study. Baek YJ; Lee YJ; Kim JI; Lee S; Kim J; Lee EH; Lee KH; Kim JH; Ahn JY; Jeong SJ; Ku NS; Yeom JS; Choi JY J Infect; 2022 Jul; 85(1):90-122. PubMed ID: 35395316 [No Abstract] [Full Text] [Related]
15. Detection of SARS-CoV-2 in Fecal Samples From Patients With Asymptomatic and Mild COVID-19 in Korea. Park SK; Lee CW; Park DI; Woo HY; Cheong HS; Shin HC; Ahn K; Kwon MJ; Joo EJ Clin Gastroenterol Hepatol; 2021 Jul; 19(7):1387-1394.e2. PubMed ID: 32534042 [TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 RNA shedding in recovered COVID-19 cases and the presence of antibodies against SARS-CoV-2 in recovered COVID-19 cases and close contacts, Thailand, April-June 2020. Chirathaworn C; Sripramote M; Chalongviriyalert P; Jirajariyavej S; Kiatpanabhikul P; Saiyarin J; Soudon C; Thienfaidee O; Palakawong Na Ayuthaya T; Brukesawan C; Chaiwanichsiri D; Intharasongkroh D; Wanlapakorn N; Chansaenroj J; Puenpa J; Yorsaeng R; Thitithanyanont A; Kitphati R; Mungaomklang A; Nagavajara P; Poovorawan Y PLoS One; 2020; 15(10):e0236905. PubMed ID: 33119712 [TBL] [Abstract][Full Text] [Related]
17. A case report of SARS-CoV-2 confirmed in saliva specimens up to 37 days after onset: Proposal of saliva specimens for COVID-19 diagnosis and virus monitoring. Tajima Y; Suda Y; Yano K J Infect Chemother; 2020 Oct; 26(10):1086-1089. PubMed ID: 32571647 [TBL] [Abstract][Full Text] [Related]
18. Prolonged viral shedding of SARS-CoV-2 and related factors in symptomatic COVID-19 patients: a prospective study. Long H; Zhao J; Zeng HL; Lu QB; Fang LQ; Wang Q; Wu QM; Liu W BMC Infect Dis; 2021 Dec; 21(1):1282. PubMed ID: 34961470 [TBL] [Abstract][Full Text] [Related]
19. Inference of Active Viral Replication in Cases with Sustained Positive Reverse Transcription-PCR Results for SARS-CoV-2. Rodríguez-Grande C; Adán-Jiménez J; Catalán P; Alcalá L; Estévez A; Muñoz P; Pérez-Lago L; García de Viedma D J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33239378 [TBL] [Abstract][Full Text] [Related]
20. Persistent viral RNA positivity during the recovery period of a patient with SARS-CoV-2 infection. Yang JR; Deng DT; Wu N; Yang B; Li HJ; Pan XB J Med Virol; 2020 Sep; 92(9):1681-1683. PubMed ID: 32330293 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]